Kinarus Therapeutics
Basel
About Kinarus Therapeutics
Kinarus is a biopharmaceutical company that develops differentiated medicines in areas of stress related inflammatory processes based on cross disease area target assessment.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $38.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2023)
- Ticker: six:KNRS
- Website: kinarus.com
- Phone: +41 79 865 8969
Industries & Categories
Biopharma, Biotechnology, Health Care, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/kinarus-therapeutics-116486 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.